NUCLEOLIN and cancer: The AS1411 aptamer could target the nucleolin protein with high expression in cancer cells and the miR-221 MB could hybridize with the corresponding miRNA-221, inhibiting the expression of miRNA-221 to achieve the therapeutic effect.